SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.

Polyrizon Ltd.

Polyrizon Ltd. Ordinary Shares

PLRZ is trending due to significant premarket gains and news regarding its nasal spray technology, sparking community discussion about potential resistance levels and whether to buy. The stock's volatility, low float, and association with Israeli stocks contribute to the intense speculation, with comparisons being drawn to similar high-flying stocks. Discussions also include potential dilution, short squeezes, and the stock's long-term viability.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath ($PATH) is trending as investors discuss its potential as an AI automation play following Needham's rating update to Hold. Community members are debating the company's growth prospects, share buybacks, and potential for a short squeeze after earnings. Talk centers around agentic AI revenue and the stock's valuation relative to peers in the tech and robotics sectors.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Bozeman, MT.

Snowflake Inc

Snowflake is trending after announcing a partnership with Palantir to integrate their AI platforms, with analysts suggesting the company is well-positioned to capitalize on AI demand. The community is discussing the potential impact of this partnership, particularly on Snowflake's data cloud and its competitive positioning against other cloud service providers. Despite a YTD surge, some are questioning the valuation and profitability.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending following its earnings report, with initial positive reactions tempered by concerns about future performance and AI disruption; the community is actively debating whether the company's growth justifies its valuation and if its AI strategy is strong enough. Some investors express skepticism, citing a lack of trust in leadership and concerns about the company's ability to adapt to the evolving tech landscape, while others remain optimistic about its long-term potential.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth ($USAR) is trending due to a newly announced supply agreement between its subsidiary, Less Common Metals, and Solvay and Arnold Magnetic Technologies to supply rare earth metals. The community is discussing the significance of this agreement for rare earth independence and potential government support, while also debating the stock's volatility and comparing it to competitors.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending as investors discuss its expansion into Canada and the potential impact on revenue, along with its recent acquisition of YourBio Health. Community members are debating whether these developments will drive the stock price higher or if it will face continued pressure from short sellers. Some see the company as undervalued, while others express concern about its ability to break through resistance levels.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

Recent data regarding uniQure's Huntington's disease treatment, AMT-130, has driven considerable discussion, especially after the FDA communicated that current data may not be sufficient for a BLA submission. The community is debating the future of QURE with some concerned about management's decisions and transparency, while others remain optimistic about the drug's potential and possibility of a buyout, citing the significant unmet need for Huntington's treatments. Concerns are circulating around the possibility of further delays and the need for additional trials.

Dollar General Corp. engages in the operation of merchandise stores. Its offerings include food, snacks, health and beauty aids, cleaning supplies, basic apparel, housewares, and seasonal items. It sells brands including Clorox, Energizer, Procter & Gamble, Hanes, Coca-Cola, Mars, Unilever, Nestle, Kimberly-Clark, Kellogg's, General Mills, and PepsiCo. The company was founded by J. L. Turner and Hurley Calister Turner Sr. in 1939 and is headquartered in Goodlettsville, TN.

Dollar General Corp.

Dollar General's recent earnings beat and raised fiscal year guidance have sparked community discussion around the stock's potential. While some investors express frustration with its past performance compared to tech stocks, others point to its value proposition and resilience in a challenging economic environment, especially with strategic initiatives like store remodels and digital upgrades. Broader context includes commentary around consumer spending habits and how tariff impacts could level the playing field for discount retailers.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

The SPDR Dow Jones Industrial Average ETF ($DIA) is trending amid speculation about a potential Fed rate cut in December, fueled by dovish comments from Fed officials and recent economic data. Community members are debating whether this rally is sustainable or if it's a bull trap before a deeper correction, with some pointing to oversold conditions in tech and potential rotation into value stocks. Discussions also involve the impact of economic data, upcoming announcements, and technical analysis on the ETF's price movement.

UP Fintech Holding Ltd. is an online brokerage firm that focuses on global investors. It provides an online trading platform that enables investors to trade in equities and other financial instruments on multiple exchanges around the world. The firm offers products and services, as well as a user experience to customers through its mobile first strategy. The company was founded by Tian Hua Wu in June 2014 and is headquartered in Singapore.

UP Fintech Holding Ltd - ADR

UP Fintech ($TIGR) is trending due to strong Q3 earnings results, including record revenue and profit, driving optimism among investors. The community highlights the company's impressive growth in client assets and funded accounts. Discussions also involve its valuation compared to competitors and potential for future growth in the Asian markets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Orgenesis (ORGS) Stock Is Down 23% Today

Orgenesis shares are trading lower by 23% during Monday's session. The company announced a 1-for-10 reverse stock split.
read more...

Orgenesis Announces Board Reshuffle and New Audit Member

Orgenesis (ORGS) just unveiled an announcement. Curtis Slipman resigned from his director position at Orgenesis Inc. for personal reasons, not due...

Orgenesis (NASDAQ:ORGS)  Shares Down 33.4%

Orgenesis Inc. (NASDAQ:ORGS - Get Free Report)'s stock price traded down 33.4% during trading on Tuesday . The stock traded as low as $0.30 and last traded at $0.39. 1,041,563 shares traded hands...

Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference

GERMANTOWN, Md., March 18, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (Nasdaq:ORGS) ( Orgenesis or the Company ), a global leader in decentralizing cell and gene therapies (CGTs), today announced...

Orgenesis awarded EUR 1.5M grant from Walloon Government

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Orgenesis Consortium Awarded  1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes

GERMANTOWN, Md., March 13, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (Nasdaq:ORGS) ( Orgenesis or the Company ), a global leader in decentralizing cell and gene therapies (CGTs), today announced...

Orgenesis Inc.'s (NASDAQ:ORGS) Price Is Right But Growth Is Lacking After Shares Rocket 119%

Orgenesis Inc. ( NASDAQ:ORGS ) shares have had a really impressive month, gaining 119% after a shaky period beforehand...

Orgenesis announces $2.3M private placement

Orgenesis announces $2.3M private placement...

Orgenesis Inc. Announces $2.3 Million Private Placement

GERMANTOWN, Md., March 04, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) ( Orgenesis or the Company ), a global leader in decentralized cell and gene therapies (CGTs), announced today...

Orgenesis Consortium Awarded  2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing

GERMANTOWN, Md., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (Nasdaq:ORGS) ( Orgenesis or the Company ), a global leader in decentralized cell and gene therapies (CGTs), today announced that...

Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies, and services in the cell and gene therapy industry. It operates through the following segments: Octomera and Therapies. The Octomera segment refers to the point of care services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.

Current Price	$0.17
Prev Close	$0.75
Open	$0.75
Dividend Yield	N/A
50-Day Moving Average	$0.4713
Beta	515.48
Avg. Volume	926.26
PE Ratio	-0.02

52-Week High	$5.89
52-Week Low	$0.0001
Market Capitalization	$923,327.00
EPS (Annual)	N/A
Price to Book	-0.03
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

ORGS
Orgenesis Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ORGS News

ORGSOrgenesis Inc